Institute for Systems Biology
Generated by GPT-5-miniExpansion Funnel Raw 105 → Dedup 5 → NER 3 → Enqueued 1
| Institute for Systems Biology | |
|---|---|
| Name | Institute for Systems Biology |
| Formation | 2000 |
| Founder | Leroy Hood |
| Location | Seattle, Washington |
| Leader title | President & CEO |
Institute for Systems Biology
The Institute for Systems Biology is an independent non-profit research organization founded in 2000 by Leroy Hood and colleagues in Seattle, Washington. It integrates experimental and computational approaches to study complex biological systems, collaborating with institutions such as Fred Hutchinson Cancer Research Center, University of Washington, Columbia University, Harvard University, and Stanford University. The institute has engaged with funding and policy bodies including the National Institutes of Health, Defense Advanced Research Projects Agency, Bill & Melinda Gates Foundation, Howard Hughes Medical Institute, and Wellcome Trust.
History
The institute was established in 2000 by Leroy Hood after roles at California Institute of Technology, University of Washington School of Medicine, and interactions with leaders from Santa Fe Institute and Microsoft Research. Early collaborations included investigators from Massachusetts Institute of Technology, Yale University, Princeton University, University of California, San Diego, and University of California, Berkeley. Foundational programs connected with efforts at National Human Genome Research Institute, Broad Institute, Sanger Centre, Cold Spring Harbor Laboratory, and European Bioinformatics Institute. Over time the institute formed strategic ties with NASA, National Science Foundation, Oak Ridge National Laboratory, Argonne National Laboratory, and Lawrence Berkeley National Laboratory to expand computational infrastructure.
Mission and Research Focus
The institute’s mission emphasizes systems biology and precision medicine, partnering with National Cancer Institute, Centers for Disease Control and Prevention, World Health Organization, American Association for Cancer Research, and American Heart Association. Research spans molecular networks, proteomics, genomics, metabolomics, and single-cell analytics, collaborating with groups at Kaiser Permanente, Mayo Clinic, Cleveland Clinic, Johns Hopkins University, and University of Pennsylvania. Projects align with translational goals linked to U.S. Department of Energy, Global Fund, GAVI, the Vaccine Alliance, and European Commission initiatives.
Scientific Contributions and Major Projects
The institute contributed to systems-level models in immunology, cancer, neurodegeneration, and infectious disease, working with teams from Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, St. Jude Children's Research Hospital, Roche, Pfizer, Novartis, and Merck. Major projects include large cohort studies in collaboration with All of Us Research Program, population health efforts tied to UK Biobank, and pandemic-response work coordinated with Centers for Disease Control and Prevention and World Health Organization. The institute developed network inference methods used by researchers at Google DeepMind, IBM Research, Microsoft Research, Amazon Web Services, and NVIDIA. Contributions have been cited alongside efforts from Francis Collins, Eric Lander, J. Craig Venter, Robert Langer, and George Church.
Facilities and Technology Platforms
Facilities include wet labs, high-throughput sequencing centers, mass spectrometry suites, and computational clusters supported by partnerships with Argonne National Laboratory, Lawrence Livermore National Laboratory, Sandia National Laboratories, Oak Ridge National Laboratory, and cloud providers such as Amazon Web Services, Google Cloud Platform, and Microsoft Azure. Instrumentation integrates platforms from Illumina, Thermo Fisher Scientific, Agilent Technologies, Bruker Corporation, and Waters Corporation. Computational work uses software and algorithms developed in cooperation with Stanford University School of Medicine, Carnegie Mellon University, University of Toronto, ETH Zurich, and Max Planck Society groups.
Education, Training, and Outreach
The institute runs training programs and fellowships with partners including University of Washington, Seattle Children’s Research Institute, Cornell University, Duke University School of Medicine, Columbia Mailman School of Public Health, and Yale School of Medicine. Outreach includes public lectures and symposia featuring speakers from National Academy of Sciences, Royal Society, American Association for the Advancement of Science, Society for Neuroscience, and American Chemical Society. The institute’s educational activities connect to initiatives such as iBiology, Coursera, edX, Cold Spring Harbor Laboratory Courses, and Wellcome Genome Campus courses.
Funding and Partnerships
Primary funding and partnerships have included grants and collaborations with National Institutes of Health, Defense Advanced Research Projects Agency, Bill & Melinda Gates Foundation, Howard Hughes Medical Institute, Chan Zuckerberg Initiative, Gates Cambridge Trust, European Research Council, Japan Society for the Promotion of Science, and Australian Research Council. Industry partnerships have included Illumina, Thermo Fisher Scientific, Roche, Pfizer, Novartis, Merck, Bristol-Myers Squibb, and Genentech. The institute also participates in consortia such as Human Cell Atlas, ENCODE Project, 1000 Genomes Project, Human Proteome Project, and Precision Medicine Initiative.